The network
Board of Advisors
The TCN Advisory Board is comprised of key members of New England’s entrepreneurial, investor, academic, political and service communities and provides critical thought leadership and feedback to the TCN Board of Directors and the TCN Program Line Managers. As part of the TCN Community, the Advisory Board uses its passion about the value of entrepreneurship to help foster the growth of New England's broader innovation economy.
|
Kevin Bitterman Prior to joining Polaris, Kevin completed his Ph.D. in genetics at Harvard Medical School. His doctoral research focused on the molecular regulation of caloric restriction and on modulation of a novel class of protein deacetylases. Kevin has authored papers in several top tier journals, is an inventor on multiple patents and is co-founder of Genocea Biosciences, Parasol Therapeutics and Sirtris Pharmaceuticals (GSK). Before obtaining his Ph.D. at Harvard Medical School, Kevin earned a B.A. with Highest Honors from Rutgers College with a major in Biological Sciences and a minor in Philosophy.
Board of Advisor meetings are facilitated through the generous support and contribution of the following TCN Sponsors:
|
